The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester). The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors.  Recordings from previous webinars are available on the Translation Manchester and CATS websites.

The next webinar of this series, hosted by Cambridge Academy of Therapeutic Sciences (CATS), will be on Tuesday 24th September from 2-3pm (via Zoom). Our guest speaker will be Dr Rabia Khan (CEO of Serna Bio) who will be giving a talk on “Mapping the Druggable Transcriptome: Lesson learned from AI-enabled RNA-small molecule drug discovery”

Rabia Khan, PhD, MBA is the founder and CEO of Serna Bio, a biotech building the world's first map of the druggable transcriptome to address novel inaccessible biology.

Before founding Serna Bio, Dr. Khan was Managing Director of Discovery Sciences at Sensyne Health Plc (now: Arcturis) where she established the scientific strategy, built the data science and discovery teams and led the pharma partnerships with Bayer, BMS, Roche and Alexion and others. She has also held senior roles at BenevolentAI and Meta (acquired by Chan Zuckerberg BioHub).

Born and raised in Pakistan, Dr. Khan is passionate about supporting diversity in technology and initiatives focused on improving access to care and availability of medicine.